Article
A Novel Prognostic Signature of Transcription Factors for the Prediction in Patients With GBM
1 Oct 2019
Abstract excerpt
Background: Although the diagnosis and treatment of glioblastoma (GBM) is significantly improved with recent progresses, there are still large heterogeneity in therapeutic effects and overall survival. The aim of this study is to analyze gene expressions of transcription factors (TFs) in GBM so as to discover new tumor markers. Methods: Differentially expressed transcription factors are identified by data mining...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
